Hologic, a Bedford, Mass.-based manufacturer of diagnostic and imaging equipment, has rebounded from losses it suffered last year, riding on strong sales of its 3D mammography systems.
Revenue from the company's breast-imaging products and related services increased 11.4%, as more customers adopted its Genius 3D mammography system. Hologic installed roughly 1,800 of its 3D systems in the U.S. this quarter.
"While this is excellent progress, we are equally encouraged that we are still less than 25% penetrated into our existing customer base, and less than 15% penetrated into the domestic market as a whole, providing significant opportunity for additional growth," Hologic President and CEO Stephen MacMillan said during a conference call.
The company's gynecological surgical business also saw strong growth, as sales of its MyoSure fibroid removal system increased 33.9%. Revenue growth in the GYN segment was 11.9%.
The company reported $47.8 million in profit for the three months ended March 28, up significantly from the $16.8 loss it reported during the same quarter last year. Revenues increased 5% to $655.5 million.
Year-to-date results were also positive. Hologic reported a profit of $77 million in the six months ended March 28, a jump from the $22.1 million loss it suffered during the same period in the prior year. Revenue was up 6% at $1.3 million.
Hologic again raised its revenue guidance for the year to between $2.6 billion and $2.62 billion, up from initial guidance of $2.57 billion to $2.6 billion.